Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients
This study has been completed.
Study NCT00530595   Information provided by Saitama Medical University

First Received on September 13, 2007.   Last Updated on September 14, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiovascular Disease
Additional conditions recognized in this trial
Cardiovascular Diseases
Additional drug interventions recognized in this trial
Angiotensin Receptor Antagonists
Candesartan
Candesartan cilexetil
Losartan
Valsartan
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Saitama Medical University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services